HCW starts Trevena at buy

HCW starts Trevena at buy

H.C. Wainwright initiated coverage of Trevena (NASDAQ:TRVN) with a “buy” rating and $11 price target. The shares were changing hands at $6.85 at mid-day on Jan. 9.

Read More

Prostate cancer study shows benefit of 3DS’ telomere signature analysis

Prostate cancer study shows benefit of 3DS’ telomere signature analysis

Data from a new study published recently in Urologic Oncology involving men with localized high-risk prostate cancer suggests that the use of 3D Signatures’ (OTCQB:TDSGF; TSX-V:DXD) technology platform, TeloView, may be a promising blood-based treatment-response biomarker in prostate cancer patients who are undergoing combined androgen deprivation therapy (ADT) and radiation therapy (RT).

Read More

Canaccord starts Natera at buy

Canaccord starts Natera at buy

Canaccord Genuity initiated coverage of Natera (NASDAQ:NTRA) with a “buy” rating and $18 price target. The stock is changing hands at $11.66 in afternoon trading on Jan. 6

Read More

Clearside receives notice for 7th U.S. patent

Clearside receives notice for 7th U.S. patent

Clearside Biomedical (NASDAQ:CLSD) has received a notice of allowance from the U.S. Patent and Trademark Office for a patent that will provide intellectual property protection for methods of treating posterior ocular disorders by non-surgically administering axitinib to the suprachoroidal space of the eye.

Read More

IntelGenx, Chemo Group sign CNS accord

IntelGenx, Chemo Group sign CNS accord

IntelGenx Technologies (OTCQX:IGXT; TSX-V:IGX) has signed a definitive agreement with Chemo Group for the co-development and commercialization of a generic tablet in the area of CNS on a worldwide basis.

Read More

Ladenburg upgrades Codexis to buy

Ladenburg upgrades Codexis to buy

Ladenburg Thalmann upgraded Codexis (NASDAQ:CDXS) to “buy” from “neutral” with a new price target of $6.25. The shares were quoted at $4.65 in afternoon trading on Jan. 4.

Read More

3DS begins trading on OTCQB and FSE

3DS begins trading on OTCQB and FSE

Common shares of 3D Signatures (TSX-V:DXD) have started trading on the OTCQB Venture Market in the U.S. under the symbol, TDSGF, and on the Frankfurt Stock Exchange (FSE) in Germany under the symbol, 3D0.

Read More